APO Research

APO RESEARCH · REPORT

Ophthalmic Suspension

Selected research

Industry Growth & Trends

Global Ophthalmic Suspension Industry Growth and Trends Forecast to 2032

Market perspective

The global Ophthalmic Suspension market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Suspension include Novartis, Merck, Pfizer, Valeant, Falcon Group, Bausch & Lomb and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Suspension market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Suspension market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Suspension market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Suspension.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmic Suspension market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Suspension Market by Company

Novartis

Merck

Pfizer

Valeant

Falcon Group

Bausch & Lomb

Allergan

Ophthalmic Suspension Segment by Type

NSAIDs

Antibacterial

Antibiotic

Antifungal

Steroids

Others

Ophthalmic Suspension Segment by Application

Hospital

Eye Clinic

Others

Ophthalmic Suspension Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Suspension market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Suspension and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Suspension.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Suspension manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmic Suspension in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of NSAIDs Table 2. Major Company of Antibacterial Table 3. Major Company of Antibiotic Table 4. Major Company of Antifungal Table 5. Major Company of Steroids Table 6. Major Company of Others Table 7. Global Ophthalmic Suspension Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 9. Global Ophthalmic Suspension Sales Market Share in Volume by Type (2021-2026) Table 10. Global Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 11. Global Ophthalmic Suspension Sales Market Share in Value by Type (2021-2026) Table 12. Global Ophthalmic Suspension Price by Type (2021-2026) & (US$/Unit) Table 13. Global Ophthalmic Suspension Sales by Type (2027-2032) & (K Units) Table 14. Global Ophthalmic Suspension Sales Market Share in Volume by Type (2027-2032) Table 15. Global Ophthalmic Suspension Sales by Type (2027-2032) & (US$ Million) Table 16. Global Ophthalmic Suspension Sales Market Share in Value by Type (2027-2032) Table 17. Global Ophthalmic Suspension Price by Type (2027-2032) & (US$/Unit) Table 18. North America Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 19. North America Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 21. Europe Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 25. Latin America Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Ophthalmic Suspension Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Ophthalmic Suspension Sales by Type (2021-2026) & (US$ Million) Table 28. Ophthalmic Suspension Industry Trends Table 29. Ophthalmic Suspension Industry Drivers Table 30. Ophthalmic Suspension Industry Opportunities and Challenges Table 31. Ophthalmic Suspension Industry Restraints Table 32. Global Ophthalmic Suspension Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Ophthalmic Suspension Revenue Market Share by Company (2021-2026) Table 34. Global Ophthalmic Suspension Sales by Company (2021-2026) & (K Units) Table 35. Global Ophthalmic Suspension Sales Share by Company (2021-2026) Table 36. Global Ophthalmic Suspension Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Ophthalmic Suspension Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Ophthalmic Suspension Major Company Production Sites and Headquarters Table 39. Global Ophthalmic Suspension Company, Product Type & Application Table 40. Global Ophthalmic Suspension Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Ophthalmic Suspension by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Ophthalmic Suspension Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Ophthalmic Suspension Sales by Region (2021-2026) & (K Units) Table 45. Global Ophthalmic Suspension Sales Market Share in Volume by Region (2021-2026) Table 46. Global Ophthalmic Suspension Sales by Region (2021-2026) & (US$ Million) Table 47. Global Ophthalmic Suspension Sales Market Share in Value by Region (2021-2026) Table 48. Global Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Ophthalmic Suspension Sales by Region (2027-2032) & (K Units) Table 50. Global Ophthalmic Suspension Sales Market Share in Volume by Region (2027-2032) Table 51. Global Ophthalmic Suspension Sales by Region (2027-2032) & (US$ Million) Table 52. Global Ophthalmic Suspension Sales Market Share in Value by Region (2027-2032) Table 53. Global Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Ophthalmic Suspension Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 56. Global Ophthalmic Suspension Sales Market Share in Volume by Application (2021-2026) Table 57. Global Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 58. Global Ophthalmic Suspension Sales Market Share in Value by Application (2021-2026) Table 59. Global Ophthalmic Suspension Price by Application (2021-2026) & (US$/Unit) Table 60. Global Ophthalmic Suspension Sales by Application (2027-2032) & (K Units) Table 61. Global Ophthalmic Suspension Sales Market Share in Volume by Application (2027-2032) Table 62. Global Ophthalmic Suspension Sales by Application (2027-2032) & (US$ Million) Table 63. Global Ophthalmic Suspension Sales Market Share in Value by Application (2027-2032) Table 64. Global Ophthalmic Suspension Price by Application (2027-2032) & (US$/Unit) Table 65. North America Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 66. North America Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 68. Europe Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 72. Latin America Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Ophthalmic Suspension Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Ophthalmic Suspension Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis Ophthalmic Suspension Product Portfolio Table 79. Novartis Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck Ophthalmic Suspension Product Portfolio Table 84. Merck Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Ophthalmic Suspension Product Portfolio Table 89. Pfizer Recent Development Table 90. Valeant Company Information Table 91. Valeant Business Overview Table 92. Valeant Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Valeant Ophthalmic Suspension Product Portfolio Table 94. Valeant Recent Development Table 95. Falcon Group Company Information Table 96. Falcon Group Business Overview Table 97. Falcon Group Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Falcon Group Ophthalmic Suspension Product Portfolio Table 99. Falcon Group Recent Development Table 100. Bausch & Lomb Company Information Table 101. Bausch & Lomb Business Overview Table 102. Bausch & Lomb Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Bausch & Lomb Ophthalmic Suspension Product Portfolio Table 104. Bausch & Lomb Recent Development Table 105. Allergan Company Information Table 106. Allergan Business Overview Table 107. Allergan Ophthalmic Suspension Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Allergan Ophthalmic Suspension Product Portfolio Table 109. Allergan Recent Development Table 110. North America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 111. North America Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 112. North America Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 113. North America Ophthalmic Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 114. North America Ophthalmic Suspension Sales Market Share Forecast by Country (2027-2032) Table 115. North America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. North America Ophthalmic Suspension Market Size by Country (2021-2026) & (US$ Million) Table 117. North America Ophthalmic Suspension Market Share by Country (2021-2026) Table 118. North America Ophthalmic Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. North America Ophthalmic Suspension Market Share Forecast by Country (2027-2032) Table 120. Europe Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 121. Europe Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 122. Europe Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 123. Europe Ophthalmic Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 124. Europe Ophthalmic Suspension Sales Market Share Forecast by Country (2027-2032) Table 125. Europe Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Europe Ophthalmic Suspension Market Size by Country (2021-2026) & (US$ Million) Table 127. Europe Ophthalmic Suspension Market Share by Country (2021-2026) Table 128. Europe Ophthalmic Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Europe Ophthalmic Suspension Market Share Forecast by Country (2027-2032) Table 130. Asia-Pacific Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 131. Asia-Pacific Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 132. Asia-Pacific Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 133. Asia-Pacific Ophthalmic Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 134. Asia-Pacific Ophthalmic Suspension Sales Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Ophthalmic Suspension Market Size by Country (2021-2026) & (US$ Million) Table 137. Asia-Pacific Ophthalmic Suspension Market Share by Country (2021-2026) Table 138. Asia-Pacific Ophthalmic Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Asia-Pacific Ophthalmic Suspension Market Share Forecast by Country (2027-2032) Table 140. Latin America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 141. Latin America Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 142. Latin America Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 143. Latin America Ophthalmic Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 144. Latin America Ophthalmic Suspension Sales Market Share Forecast by Country (2027-2032) Table 145. Latin America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Latin America Ophthalmic Suspension Market Size by Country (2021-2026) & (US$ Million) Table 147. Latin America Ophthalmic Suspension Market Share by Country (2021-2026) Table 148. Latin America Ophthalmic Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Latin America Ophthalmic Suspension Market Share Forecast by Country (2027-2032) Table 150. Middle East and Africa Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 151. Middle East and Africa Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 152. Middle East and Africa Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 153. Middle East and Africa Ophthalmic Suspension Sales Forecast by Country (2027-2032) & (K Units) Table 154. Middle East and Africa Ophthalmic Suspension Sales Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Ophthalmic Suspension Market Size by Country (2021-2026) & (US$ Million) Table 157. Middle East and Africa Ophthalmic Suspension Market Share by Country (2021-2026) Table 158. Middle East and Africa Ophthalmic Suspension Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Middle East and Africa Ophthalmic Suspension Market Share Forecast by Country (2027-2032) Table 160. Key Raw Materials Table 161. Raw Materials Key Suppliers Table 162. Ophthalmic Suspension Distributors List Table 163. Ophthalmic Suspension Customers List Table 164. Research Programs/Design for This Report Table 165. Authors List of This Report Table 166. Secondary Sources Table 167. Primary Sources List of Figures Figure 1. Ophthalmic Suspension Image Figure 2. Global Ophthalmic Suspension Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Suspension Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Suspension Sales (2021-2032) & (K Units) Figure 5. NSAIDs Image Figure 6. Global NSAIDs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antibacterial Image Figure 8. Global Antibacterial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Antibiotic Image Figure 10. Global Antibiotic Sales YoY Growth (2021-2032) & (K Units) Figure 11. Antifungal Image Figure 12. Global Antifungal Sales YoY Growth (2021-2032) & (K Units) Figure 13. Steroids Image Figure 14. Global Steroids Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Ophthalmic Suspension Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Ophthalmic Suspension Market Share by Type 2025 VS 2032 Figure 19. North America Ophthalmic Suspension Sales Market Share in Volume by Type in 2025 Figure 20. North America Ophthalmic Suspension Sales Market Share in Value by Type in 2025 Figure 21. Europe Ophthalmic Suspension Sales Market Share in Volume by Type in 2025 Figure 22. Europe Ophthalmic Suspension Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Ophthalmic Suspension Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Ophthalmic Suspension Sales Market Share in Value by Type in 2025 Figure 25. Latin America Ophthalmic Suspension Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Ophthalmic Suspension Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Ophthalmic Suspension Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Ophthalmic Suspension Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Ophthalmic Suspension Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Eye Clinic Image Figure 34. Global Eye Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Ophthalmic Suspension Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Ophthalmic Suspension Market Share by Application 2025 VS 2032 Figure 39. North America Ophthalmic Suspension Sales Market Share in Volume by Application in 2025 Figure 40. North America Ophthalmic Suspension Sales Market Share in Value by Application in 2025 Figure 41. Europe Ophthalmic Suspension Sales Market Share in Volume by Application in 2025 Figure 42. Europe Ophthalmic Suspension Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Ophthalmic Suspension Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Ophthalmic Suspension Sales Market Share in Value by Application in 2025 Figure 45. Latin America Ophthalmic Suspension Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Ophthalmic Suspension Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Ophthalmic Suspension Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Ophthalmic Suspension Sales Market Share in Value by Application in 2025 Figure 49. North America Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Ophthalmic Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Ophthalmic Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Ophthalmic Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Ophthalmic Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Ophthalmic Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Ophthalmic Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Ophthalmic Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Ophthalmic Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Ophthalmic Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Ophthalmic Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Ophthalmic Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Ophthalmic Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Ophthalmic Suspension Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Ophthalmic Suspension Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Ophthalmic Suspension Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Ophthalmic Suspension Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Ophthalmic Suspension Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Antibacterial
  • Antibiotic
  • Antifungal
  • Steroids
  • Others
Applications
  • Hospital
  • Eye Clinic
  • Others
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • Valeant
  • Falcon Group
  • Bausch & Lomb
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Suspension Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmic Suspension Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmic Suspension Market by Type
  6. 1.3.1 NSAIDs
  7. 1.3.2 Antibacterial
  8. 1.3.3 Antibiotic
  9. 1.3.4 Antifungal
  10. 1.3.5 Steroids
  11. 1.3.6 Others
  12. 1.4 Global Ophthalmic Suspension Market Size by Type
  13. 1.4.1 Global Ophthalmic Suspension Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Ophthalmic Suspension Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Ophthalmic Suspension Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Ophthalmic Suspension Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Ophthalmic Suspension Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Ophthalmic Suspension Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Ophthalmic Suspension Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Ophthalmic Suspension Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmic Suspension Industry Trends
  2. 2.2 Ophthalmic Suspension Industry Drivers
  3. 2.3 Ophthalmic Suspension Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Suspension Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmic Suspension Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmic Suspension Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmic Suspension Price (2021-2026)
  4. 3.4 Global Ophthalmic Suspension Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Suspension Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmic Suspension Company, Product Type & Application
  7. 3.7 Global Ophthalmic Suspension Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Suspension Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Suspension Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Suspension Tier 1, Tier 2, and Tier 3
4 Ophthalmic Suspension Regional Status and Outlook
  1. 4.1 Global Ophthalmic Suspension Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmic Suspension Historic Market Size by Region
  3. 4.2.1 Global Ophthalmic Suspension Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmic Suspension Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmic Suspension Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmic Suspension Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmic Suspension Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmic Suspension Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmic Suspension Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmic Suspension by Application
  1. 5.1 Ophthalmic Suspension Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Eye Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ophthalmic Suspension Market Size by Application
  6. 5.2.1 Global Ophthalmic Suspension Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ophthalmic Suspension Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ophthalmic Suspension Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ophthalmic Suspension Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ophthalmic Suspension Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ophthalmic Suspension Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ophthalmic Suspension Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ophthalmic Suspension Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Ophthalmic Suspension Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Ophthalmic Suspension Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Ophthalmic Suspension Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Valeant
  20. 6.4.1 Valeant Company Information
  21. 6.4.2 Valeant Business Overview
  22. 6.4.3 Valeant Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Valeant Ophthalmic Suspension Product Portfolio
  24. 6.4.5 Valeant Recent Developments
  25. 6.5 Falcon Group
  26. 6.5.1 Falcon Group Company Information
  27. 6.5.2 Falcon Group Business Overview
  28. 6.5.3 Falcon Group Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Falcon Group Ophthalmic Suspension Product Portfolio
  30. 6.5.5 Falcon Group Recent Developments
  31. 6.6 Bausch & Lomb
  32. 6.6.1 Bausch & Lomb Company Information
  33. 6.6.2 Bausch & Lomb Business Overview
  34. 6.6.3 Bausch & Lomb Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bausch & Lomb Ophthalmic Suspension Product Portfolio
  36. 6.6.5 Bausch & Lomb Recent Developments
  37. 6.7 Allergan
  38. 6.7.1 Allergan Company Information
  39. 6.7.2 Allergan Business Overview
  40. 6.7.3 Allergan Ophthalmic Suspension Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Allergan Ophthalmic Suspension Product Portfolio
  42. 6.7.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmic Suspension Sales by Country
  2. 7.1.1 North America Ophthalmic Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmic Suspension Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmic Suspension Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmic Suspension Market Size by Country
  6. 7.2.1 North America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmic Suspension Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmic Suspension Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmic Suspension Sales by Country
  2. 8.1.1 Europe Ophthalmic Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmic Suspension Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmic Suspension Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmic Suspension Market Size by Country
  6. 8.2.1 Europe Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmic Suspension Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmic Suspension Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmic Suspension Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmic Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmic Suspension Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmic Suspension Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmic Suspension Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmic Suspension Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmic Suspension Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmic Suspension Sales by Country
  2. 10.1.1 South America Ophthalmic Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmic Suspension Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmic Suspension Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmic Suspension Market Size by Country
  6. 10.2.1 South America Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmic Suspension Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmic Suspension Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmic Suspension Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmic Suspension Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmic Suspension Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmic Suspension Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmic Suspension Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmic Suspension Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmic Suspension Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmic Suspension Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmic Suspension Value Chain Analysis
  2. 12.1.1 Ophthalmic Suspension Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmic Suspension Production Mode & Process
  7. 12.2 Ophthalmic Suspension Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmic Suspension Distributors
  10. 12.2.3 Ophthalmic Suspension Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research